NCT03934190 is a clinical trial in Macular Pucker, sponsored by Changhua Christian Hospital.

Who is sponsoring NCT03934190?

NCT03934190 is sponsored by Changhua Christian Hospital.

What condition does NCT03934190 study?

NCT03934190 studies Macular Pucker, Macular Cyst.

Is NCT03934190 still recruiting?

NCT03934190 is currently completed. Last updated 2 May 2019.

Last reviewed 2019-05-02 · How we verify

NCT03934190

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Inner Nuclear Macular Microcyst is a Risk Factor for Macular Cystoid Changes After Phacoemulsification in Eyes With Previous Vitrectomy and Macular Pucker Removal

Completed Last updated 2 May 2019

What this trial tests

trial in Macular Pucker in 46 participants. Completed in 31 March 2019.

Timeline

1 October 2014

Primary endpoint
31 January 2019

31 March 2019

Quick facts

Lead sponsor	Changhua Christian Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	46
Start date	1 October 2014
Primary completion	31 January 2019
Estimated completion	31 March 2019

Conditions studied

Macular Pucker — all drugs for Macular Pucker →
Macular Cyst — all drugs for Macular Cyst →

Sponsor

Changhua Christian Hospital

Who can join

Adults 50 to 80, any sex, with Macular Pucker or Macular Cyst. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the visual acuity, macular thickness, morphological changes after cataract surgery in eyes with previous vitrectomy for macular pucker. Associated risk factors were also investigated.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Changhua Christian Hospital trials

Trials by the same sponsor.

NCT07040215 — Effects on Subacute Stroke With Robotic Assistive Gait Training · NA · recruiting
NCT06970834 — Explore the Effect of Bitter Melon Peptides on Glycemic Control and Metabolic Indicators in Diabetic Patients · NA · not yet recruiting
NCT06432153 — Tampa Scale of Kinesiophobia for Heart Taiwan Version Validation · not yet recruiting
NCT06334237 — Psychosomatic Factors Influencing the Efficacy of Holistic Care for Migraine · recruiting
NCT06118294 — Efficacy of Probiotics for Parkinson Disease (PD) · NA · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03934190 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Changhua Christian Hospital
Last refreshed: 2 May 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03934190.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing